GLOBUS MEDICAL, INC. (GMED) Shareholder Equity
- 2026-06-30: Additional Paid in CapitalUSD $3.23B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $11.20M; Retained Earnings (Accumulated Deficit)USD $1.53B; Stockholders' Equity Attributable to ParentUSD $4.77B.
- 2026-03-31: Additional Paid in CapitalUSD $3.21B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $14.40M; Retained Earnings (Accumulated Deficit)USD $1.51B; Stockholders' Equity Attributable to ParentUSD $4.73B.
- 2025-12-31: Additional Paid in CapitalUSD $3.17B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $15.35M; Retained Earnings (Accumulated Deficit)USD $1.39B; Stockholders' Equity Attributable to ParentUSD $4.57B.
- 2025-09-30: Additional Paid in CapitalUSD $3.10B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $10.93M; Retained Earnings (Accumulated Deficit)USD $1.29B; Stockholders' Equity Attributable to ParentUSD $4.40B.
GLOBUS MEDICAL, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock Acquired, Average Cost Per Share USD/shares | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Treasury Stock, Value, Acquired, Cost Method USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.23B | $11.20M | $1.53B | $4.77B | 3 month · $13.42M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $3.21B | $14.40M | $1.51B | $4.73B | 3 month · $12.79M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $3.17B | $15.35M | $1.39B | $4.57B | 12 month · $49.34M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $3.10B | $10.93M | $1.29B | $4.40B | 3 month · $11.51M | 3 month · 60.12 9 month · 72.55 | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $3.07B | $10.24M | $1.21B | $4.30B | 3 month · $13.15M | 3 month · 60.81 6 month · 75.45 | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $3.05B | $-2.17M | $1.04B | $4.09B | 3 month · $13.32M | 3 month · 77.91 | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $3.03B | $-6.86M | $1.15B | $4.18B | 12 month · $54.29M | 12 month · 52.14 | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $2.95B | $-6.96M | $1.13B | $4.07B | 3 month · $12.30M | 9 month · 52.14 | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $2.91B | $-11.85M | $1.07B | $3.98B | 3 month · $12.84M | 3 month · 49.67 6 month · 52.14 | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $2.89B | $-11.04M | $1.05B | $3.92B | 3 month · $17.28M | 3 month · 52.18 | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $2.87B | $-10.19M | $1.14B | $4.00B | 12 month · $52.77M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $2.86B | $-18.74M | $1.35B | $4.19B | 3 month · $22.76M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $657.24M | $-19.07M | $1.35B | $1.99B | 3 month · $8.64M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $645.06M | $-19.42M | $1.29B | $1.91B | 3 month · $9.03M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $630.95M | $-24.63M | $1.24B | $1.85B | 3 month · $8.66M 12 month · $33.47M | 36 month · 49.42 | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $606.35M | $-32.23M | $1.19B | $1.76B | 3 month · $8.43M | 33 month · 49.42 | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $581.91M | $-25.37M | $1.14B | $1.70B | 3 month · $8.02M | 3 month · 61.45 30 month · 49.42 | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $570.08M | $-17.17M | $1.23B | $1.79B | 3 month · $8.35M | 27 month · 38.91 | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $553.79M | $-6.77M | $1.19B | $1.74B | 3 month · $7.96M 12 month · $31.25M | 24 month · 38.91 | (m) | (m) | (m) | (m) | (m) |
| 2021-09-30 | $542.05M | $-3.05M | $1.18B | $1.72B | 3 month · $7.62M | 21 month · 38.91 | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | $508.79M | $-1.57M | $1.13B | $1.64B | 3 month · $7.79M | 18 month · 38.91 | (m) | (m) | (m) | (m) | (m) |
| 2021-03-31 | $474.31M | $-1.82M | $1.09B | $1.56B | 3 month · $7.88M | 15 month · 38.91 | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $457.16M | $3.96M | $1.05B | $1.51B | 3 month · $6.00M | 12 month · 38.91 | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $422.77M | $2.21M | $992.12M | $1.42B | 3 month · $7.01M | 9 month · 38.91 | (m) | (m) | (m) | 9 month · $716.00K | (m) |
| 2020-06-30 | $387.61M | $1.30M | $947.91M | $1.34B | 3 month · $7.43M | 3 month · 39.95 6 month · 38.91 | (m) | (m) | (m) | 6 month · $949.00K | (m) |
| 2020-03-31 | $369.98M | $-6.27M | $999.55M | $1.36B | 3 month · $6.90M | 3 month · 38.49 | (m) | (m) | 3 month · $-73.86M | 3 month · $-1.19M | (m) |
| 2019-12-31 | $357.32M | $-2.90M | $1.05B | $1.40B | 3 month · $6.52M 12 month · $26.42M | (m) | (m) | (m) | (m) | 12 month · $-1.17M | (m) |
| 2019-09-30 | $339.12M | $-2.83M | $1.00B | $1.34B | 3 month · $6.98M 9 month · $19.90M | (m) | (m) | (m) | (m) | 9 month · $1.24M | (m) |
| 2019-06-30 | $325.06M | $-1.73M | $964.09M | $1.29B | 3 month · $6.38M 6 month · $12.92M | (m) | (m) | (m) | (m) | 6 month · $1.16M | (m) |
| 2019-03-31 | $316.67M | $-5.48M | $925.93M | $1.24B | 3 month · $6.54M | (m) | (m) | (m) | (m) | 3 month · $554.00K | (m) |
| 2018-12-31 | $299.87M | $-7.17M | $892.72M | $1.19B | 3 month · $4.93M 12 month · $22.22M | (m) | (m) | (m) | (m) | 12 month · $-15.00K | (m) |
| 2018-09-30 | $291.88M | $-6.83M | $855.97M | $1.14B | 3 month · $5.63M 9 month · $17.29M | (m) | (m) | (m) | (m) | 9 month · $-13.00K | (m) |
| 2018-06-30 | $283.13M | $-6.81M | $820.76M | $1.10B | 3 month · $5.55M 6 month · $11.66M | (m) | (m) | (m) | (m) | 6 month · $-5.00K | (m) |
| 2018-03-31 | $253.76M | $-2.77M | $775.78M | $1.03B | 3 month · $6.11M | (m) | (m) | (m) | (m) | 3 month · $1.00K | (m) |
| 2017-12-31 | $238.34M | $-6.91M | $736.25M | $967.78M | 12 month · $14.88M | (m) | (m) | (m) | (m) | 12 month · $-3.00K | 12 month · $11.73M |
| 2017-09-30 | $229.47M | $-6.18M | $711.87M | $935.26M | 9 month · $10.81M | (m) | (m) | (m) | (m) | 9 month · $-2.00K | (m) |
| 2017-06-30 | $224.80M | $-5.87M | $686.28M | $905.30M | 6 month · $7.16M | (m) | (m) | (m) | (m) | 6 month · $-2.00K | (m) |
| 2017-03-31 | $217.26M | $-6.08M | $657.61M | $868.88M | 3 month · $3.54M | (m) | (m) | (m) | (m) | 3 month · $-46.00K | (m) |
| 2016-12-31 | $211.72M | $-8.64M | $628.90M | $832.08M | 12 month · $11.65M | (m) | (m) | (m) | (m) | 12 month · $26.00K | 12 month · $1.57M |
| 2016-09-30 | $207.18M | $-1.76M | $604.60M | $810.12M | 9 month · $8.64M | (m) | (m) | (m) | (m) | 9 month · $24.00K | 9 month · $1.48M |
| 2016-06-30 | $202.80M | $-1.74M | $578.37M | $779.53M | 6 month · $5.83M | (m) | (m) | (m) | (m) | 6 month · $0.00 | 6 month · $764.00K |
| 2016-03-31 | $197.88M | $-1.65M | $552.57M | $748.88M | 3 month · $2.84M | (m) | (m) | (m) | (m) | 3 month · $0.00 | 3 month · $510.00K |
| 2015-12-31 | $192.63M | $-1.96M | $524.56M | $715.32M | 12 month · $9.86M | (m) | (m) | (m) | (m) | 12 month · $12.00K | 12 month · $2.05M |
| 2015-09-30 | $188.60M | $-1.74M | $486.96M | $673.92M | 9 month · $7.08M | (m) | (m) | (m) | (m) | 9 month · $3.00K | 9 month · $1.97M |
| 2015-06-30 | $184.24M | $-1.69M | $460.48M | $643.12M | 6 month · $4.67M | (m) | (m) | (m) | (m) | 6 month · $2.00K | 6 month · $1.32M |
| 2015-03-31 | $179.48M | $-1.83M | $436.42M | $614.16M | 3 month · $2.13M | (m) | (m) | (m) | (m) | 3 month · $1.00K | 3 month · $684.00K |
| 2014-12-31 | $175.24M | $-1.66M | $411.77M | $585.45M | 12 month · $7.11M | (m) | (m) | (m) | (m) | (m) | 12 month · $4.41M |
| 2014-09-30 | $170.88M | $-1.31M | $384.14M | $553.81M | 9 month · $5.21M | (m) | (m) | $94.00K | (m) | 9 month · $7.00K | 9 month · $4.04M |
| 2014-06-30 | $168.01M | $-867.00K | $361.07M | $528.31M | 6 month · $3.55M | (m) | (m) | $94.00K | (m) | 6 month · $6.00K | 6 month · $3.84M |
| 2014-03-31 | $162.55M | $-1.01M | $340.43M | $502.06M | 3 month · $1.93M | (m) | (m) | $94.00K | (m) | 3 month · $6.00K | 3 month · $2.79M |
| 2013-12-31 | $153.99M | $-1.01M | $319.29M | $472.36M | 12 month · $5.18M | (m) | (m) | $93.00K | (m) | (m) | 12 month · $4.76M |
| 2013-09-30 | $151.10M | $-1.12M | $298.30M | $448.38M | 9 month · $3.87M | (m) | (m) | $93.00K | (m) | 9 month · $-4.00K | 9 month · $4.52M |
| 2013-06-30 | $145.42M | $-1.37M | $277.99M | $422.13M | 6 month · $2.48M | (m) | (m) | $93.00K | (m) | (m) | 6 month · $2.19M |
| 2013-03-31 | $139.00M | $-1.35M | $270.57M | $408.30M | 3 month · $1.31M | (m) | (m) | $92.00K | (m) | (m) | 3 month · $303.00K |
| 2012-12-31 | $136.50M | $-767.00K | $250.68M | $386.50M | 12 month · $4.63M | (m) | $0.00 | $91.00K | (m) | (m) | 12 month · $2.66M |
| 2012-09-30 | $135.08M | $-815.00K | $229.91M | $364.26M | 9 month · $3.68M | (m) | $0.00 | $91.00K | (m) | (m) | 9 month · $2.64M |
| 2012-06-30 | $109.27M | $-1.13M | $213.42M | $321.69M | (m) | (m) | $51.00K | $73.00K | (m) | (m) | (m) |
| 2011-12-31 | $106.71M | $-1.20M | $176.85M | $282.48M | 12 month · $3.29M | (m) | $51.00K | $73.00K | (m) | (m) | 12 month · $-170.00K |
| 2010-12-31 | (m) | (m) | (m) | $228.19M | 12 month · $4.03M | (m) | (m) | (m) | (m) | (m) | 12 month · $787.00K |
| 2009-12-31 | (m) | (m) | (m) | $167.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |